MGRM:NSD-Monogram Orthopaedics Inc. Common Stock (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 2.49

Change

0.00 (0.00)%

Market Cap

USD 0.09B

Volume

0.21M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

N/A

USD 27.48B
PODD Insulet Corporation

N/A

USD 16.52B
BRKR Bruker Corporation

N/A

USD 8.98B
MASI Masimo Corporation

N/A

USD 7.71B
PRCT Procept Biorobotics Corp

N/A

USD 4.99B
TMDX TransMedics Group Inc

N/A

USD 4.17B
AXNX Axonics Modulation Technologie..

N/A

USD 3.60B
NARI Inari Medical Inc

N/A

USD 2.85B
LIVN LivaNova PLC

N/A

USD 2.80B
QDEL Quidel Corporation

N/A

USD 2.62B

ETFs Containing MGRM

EEA:PA BNP Paribas Easy FTSE EPR.. 3.91 % 0.00 %

N/A

USD 0.12B
EEE:PA BNP Paribas Easy FTSE EPR.. 3.91 % 0.00 %

N/A

USD 0.19B
EEAA:XETRA BNP Paribas Easy FTSE EPR.. 3.91 % 0.00 %

N/A

USD 0.20B
EMIF iShares Emerging Markets .. 0.00 % 0.75 %

N/A

USD 8.82M
UAE iShares MSCI UAE ETF 0.00 % 0.59 %

N/A

USD 0.04B
EEAA:F BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

N/A

N/A
IM2A:F BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

N/A

N/A
IM2A:XETRA BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

N/A

USD 0.20B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.62% 54% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.62% 54% F 27% F
Trailing 12 Months  
Capital Gain -38.21% 46% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.21% 46% F 24% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -10.86% 33% F 25% F
Dividend Return -10.86% 33% F 24% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.48% 97% N/A 76% C+
Risk Adjusted Return -53.00% 19% F 17% F
Market Capitalization 0.09B 47% F 37% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector